ZILXI
NDC 69489-212, Minocycline, aerosol, foam, from Journey Medical Corporation.
- Product NDC
- 69489-212
- Status
- Listed
- Labeler
- Journey Medical Corporation
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213690
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69489-212 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MINOCYCLINE HYDROCHLORIDE15 mg/g
Pharmacologic classes
Decreased Prothrombin Activity [PE]; Tetracycline-class Drug [EPC]; Tetracyclines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69489-212-03 | 69489021203 | 1 CAN in 1 CARTON (69489-212-03) / 3 g in 1 CAN |
| 69489-212-30 | 69489021230 | 1 CAN in 1 CARTON (69489-212-30) / 30 g in 1 CAN |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cbffa96e-2446-43cf-ba5e-38c645302afd
Use it
Look up 69489-212 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69489-212 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69489-212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.